-0.21 | -0.38%
- Tim Cook Should Tell Congress to Kiss His Ass
- Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma
- 5 Worst Home Renovation Projects
- How the New York Hedge Funds Lost Their Shirts on Tesla
- What You Wear to the Office Still Matters
|
|
|
|
|
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 54.92 |
| 52 Week High | 58.41 |
| 52 Week Low | 39.93 |
| Avg. Daily Vol. (Mil) | 5.09 |
| Beta (3 year) | 0.42 |
| Share Related Items | |
| Mkt Cap (Mil) | 61,870.76 |
| Shares Out (Mil) | 1,126.56 |
| Float (Mil) | 992.73 |
| Dividend Information | |
| Yield % | 3.60 |
| Annual Dividend | 1.96 |
| Payout Ratio | 47.00 |
| Financial Strength | |
| Quick Ratio | 1.20 |
| Current Ratio | 1.60 |
| LT Debt/ Equity | 0.30 |
| Total Debt / Equity | 0.37 |
| Valuation Ratios | |
| Price Earnings | 13.20 |
| Price/Sales | 2.74 |
| Price/Book | 4.14 |
| Price/Cash Flow | 8.70 |
| Per Share Data | |
| Earnings | 4.17 |
| Sales | 20.06 |
| Book Value | 13.27 |
| Cash Flow | 6.30 |
| Business Summary | |
|---|---|
| Eli Lilly and Company is a drug manufacturing company. It discovers, develops, manufactures, and sells products in two business segments: human pharmaceutical products and animal health products. | |
| General Information | |
| Lilly Corporate Center
Drop Code 1112 Indianapolis, IN 46285 |
|
| www.lilly.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 38350 | |
| CEO: Mr. Derica W. Rice | |
| Short Interest | |
| Current Month (Mil) | 14.49 |
| Previous Month (Mil) | 14.97 |
| Short Interest Ratio (Days) | 3.30 |
| Management Effectiveness | |
| Return on Equity | 37.70 |
| Return on Assets | 17.50 |
| Return on Investments | 29.10 |
| Profitability | |
| Gross Margin | 85.40 |
| EBIT Margin | 27.40 |
| Profit Margin | 24.90 |
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
|
|
Brokerage Partners
|
|
|
|
|
|
|
|
Most Commented
Advertising Partners
|
|
|
|
We respect your privacy.